Nanoparticles Target Cardiovascular Disease
Harvard Medical School and Massachusetts Institute of Technology (US) researchers build targeted nanoparticles with ability to cling to artery walls and release medicine slowly. Heralding a potentially major advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease, Omid Farokhzad, from Harvard Medical School and Robert Langer, from the Massachusetts …